PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Ann: NEW FINANCIAL YEAR UPDATE, page-17

  1. 3,147 Posts.
    lightbulb Created with Sketch. 331
    It's a solid update and even if there is some regurgitation I think any positive re-inforcement is useful in this current market. The NFL results are all about media, and then hopefully new investor, attention. I partially take your point though as while it may potentially buoy the SP I'm not sure if it's really going to matter for long term investors where TGA approval and more importantly FDA approval are the golden eggs. Could be a good opportunity to sell some parcels though.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.